二尖瓣置换患者二尖瓣钙化是否预示更差生存?
该回顾性研究纳入496例孤立初次二尖瓣置换患者,评估二尖瓣钙化(MAC)对术后结局的影响。结果表明,MAC患者合并症多、晚期死亡率较高,但多因素分析中MAC并非独立死亡危险因素;对MAC采用保守清理策略可获得满意结果。
要点
- MAC患者晚期死亡风险未校正HR 1.62(95%CI 1.20-2.18),但多因素分析后非独立危险因素。
- MAC患者术后透析率更高(环形MAC,p=0.006),前叶及交界钙化者起搏器植入率更高。
- 对MAC采用保守清理策略,手术死亡率MAC组1% vs 非MAC组2%,无显著差异(p=0.466)。
核心结论
- 对二尖瓣钙化采用保守清理策略可获得满意结果。
- MAC患者合并症多导致生存较差,但MAC本身并非死亡独立危险因素。
研究设计与样本
- 纳入孤立初次二尖瓣置换496例,排除合并心脏手术1068例、再次置换110例、感染性心内膜炎36例。
主要发现
- 二尖瓣钙化见于169例(34%),其中MAC 115例(23%)。
- MAC组手术死亡率1%(n=1),非MAC组2%(n=9),差异无统计学意义(p=0.466)。
- MAC与晚期死亡相关,未校正HR 1.62(95%CI 1.20-2.18)。
- 多因素分析中年龄、糖尿病、透析、高血压、既往主动脉瓣手术、既往冠脉搭桥、生物瓣置换为死亡独立危险因素,MAC非独立危险因素。
- 二尖瓣钙化患者卒中率更高(p=0.040),前叶及交界钙化者起搏器植入率更高(p=0.010,p=0.001),环形MAC者术后透析率更高(p=0.006)。
临床怎么用
- 对合并MAC的二尖瓣置换患者,可采用保守的瓣环清理策略。
- MAC患者应重视合并症评估与管理,其生存劣势主要归因于合并症而非钙化本身。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mitral annular calcification (MAC) is associated with worse outcomes after mitral valve replacement (MVR). With limited data available on long-term outcomes, we reviewed our experience of MVR in presence of MAC. METHODS: A retrospective review of 1,710 consecutive patients who underwent MVR between January 2000 and December 2015 was performed. Patients with isolated primary MVR (n = 496) were included, whereas patients with concomitant cardiac surgery (n = 1,068), previous MVR (n = 110), and mitral valve (MV) endocarditis (n = 36) were excluded. MV calcification was classified as MAC present in anterior/posterior annulus and vertically at the level of leaflets/subvalvular apparatus. A conservative approach towards annular debridement was followed. RESULTS: Our sample's mean age was 64.4 ± 14.1 years, and included 279 (56%) women. MV calcification was observed in 169 (34%) patients with MAC in 115 (23%). Older age, higher ejection fraction, peripheral vascular disease, diabetes, dialysis, and previous aortic valve surgery were associated with increased prevalence of MAC. Patients with MV calcification had higher stroke rate (p = 0.040), patients with anterior leaflet and commissural calcification had higher pacemaker implantation (p = 0.010, p = 0.001, respectively), and patients with circumferential MAC had higher postoperative dialysis (p = 0.006). Operative mortality was not significantly different (p = 0.466) between MAC (n = 1, 1%) and non-MAC (n = 9, 2%) patients. MAC was associated with late mortality (unadjusted hazard ratio, 1.62; 95% confidence interval, 1.20 to 2.18), though on multivariable analysis age, diabetes, dialysis, hypertension, previous aortic valve surgery, previous coronary artery bypass grafting, and MVR with a bioprosthetic valve were found to be independent risk factors for mortality whereas MAC was not. CONCLUSIONS: A conservative approach to treat MAC achieves satisfactory results. Patients with MAC have significant comorbidities contributing to a worse survival, though MAC in itself is not a risk factor for mortality.
引用
- Saran N, Greason KL, Schaff HV, et al. Does Mitral Valve Calcium in Patients Undergoing Mitral Valve Replacement Portend Worse Survival? Ann Thorac Surg. 2018. PMID: 30391339. doi:10.1016/j.athoracsur.2018.07.098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。